Date published: 2026-4-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

BMP-8 Inhibitors

BMP-8 inhibitors belong to a specific chemical class that encompasses a group of compounds known for their ability to modulate the activity of bone morphogenetic protein 8 (BMP-8). BMP-8 is a member of the transforming growth factor beta (TGF-β) superfamily, which plays crucial roles in various biological processes, particularly in the regulation of bone and cartilage development, as well as tissue homeostasis. BMP-8 inhibitors are designed to specifically interact with BMP-8 molecules and interfere with their normal signaling pathways. These inhibitors typically possess unique structural features that enable them to bind to BMP-8 and hinder its binding to its receptors, thereby impeding the downstream signaling cascade. By blocking the interaction between BMP-8 and its receptors, these inhibitors disrupt the transmission of cellular signals that are typically initiated by BMP-8. This modulation of BMP-8 activity can have far-reaching effects on multiple cellular processes, as BMP-8 is involved in diverse physiological functions, including embryonic development, tissue regeneration, and cellular differentiation.

BMP-8 inhibitors are designed to be selective and exhibit high affinity for BMP-8, allowing them to specifically target this protein without interfering with the function of other members of the TGF-β superfamily. The structural characteristics of these inhibitors may vary, ranging from small molecules to larger compounds, depending on the specific chemical design. Researchers employ a variety of synthetic and computational approaches to develop novel BMP-8 inhibitors with enhanced potency, specificity, and pharmacokinetic properties. Through their ability to modulate BMP-8 signaling, these inhibitors provide valuable tools for investigating the biological roles of BMP-8 in various contexts. They serve as important research reagents to dissect the intricate mechanisms underlying BMP-8-mediated cellular processes, contributing to a deeper understanding of the fundamental biology associated with BMP-8. The development and utilization of BMP-8 inhibitors pave the way for advancements in the field of molecular biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

DMH-1

1206711-16-1sc-361171
sc-361171B
sc-361171A
sc-361171C
10 mg
25 mg
50 mg
100 mg
$213.00
$318.00
$632.00
$1047.00
2
(0)

DMH1 is a selective small molecule inhibitor of BMP signaling that has been shown to block the activity of multiple BMP ligands, including BMP-8.

5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline

1432597-26-6sc-476318
5 mg
$380.00
(0)

LDN-212854 is a newer compound that has been developed as a BMP signaling inhibitor, but specific information about its activity against BMP-8 is limited.